These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4092795)

  • 1. Incidence and significance of organ-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo.
    Betterle C; Caretto A; De Zio A; Pedini B; Veller-Fornasa C; Cecchetto A; Accordi F; Peserico A
    Dermatologica; 1985; 171(6):419-23. PubMed ID: 4092795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-specific autoantibodies in vitiligo patients and their relatives.
    Mandry RC; Ortíz LJ; Lugo-Somolinos A; Sánchez JL
    Int J Dermatol; 1996 Jan; 35(1):18-21. PubMed ID: 8838923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study.
    Korkij W; Soltani K; Simjee S; Marcincin PG; Chuang TY
    J Cutan Pathol; 1984 Dec; 11(6):522-30. PubMed ID: 6520261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study.
    Ingordo V; Cazzaniga S; Raone B; Digiuseppe MD; Musumeci ML; Fai D; Pellegrino M; Pezzarossa E; Di Lernia V; Battarra VC; Sirna R; Patrizi A; Naldi L
    Dermatology; 2014; 228(3):240-9. PubMed ID: 24603479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of thyroid dysfunction in patients with vitiligo.
    Hegedüs L; Heidenheim M; Gervil M; Hjalgrim H; Høier-Madsen M
    Acta Derm Venereol; 1994 Mar; 74(2):120-3. PubMed ID: 7911617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies and their clinical significance in a black vitiligo population.
    Grimes PE; Halder RM; Jones C; Chakrabarti SG; Enterline J; Minus HR; Kenney JA
    Arch Dermatol; 1983 Apr; 119(4):300-3. PubMed ID: 6601472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-thyroid peroxidase antibody and vitiligo: a controlled study.
    Daneshpazhooh M; Mostofizadeh G M; Behjati J; Akhyani M; Robati RM
    BMC Dermatol; 2006 Mar; 6():3. PubMed ID: 16526964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of antismooth muscle antibody in Korean vitiligo patients.
    Hann SK; Im S; Kim HI; Kim HS; Lee YJ; Park YK
    J Dermatol; 1993 Nov; 20(11):679-83. PubMed ID: 8300936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoantibodies in vitiligo. Clinical significance].
    Morgan M; Castells A; Ramírez A
    Med Cutan Ibero Lat Am; 1986; 14(2):139-42. PubMed ID: 3528710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in patients with vitiligo.
    Brostoff J
    Lancet; 1969 Jul; 2(7613):177-8. PubMed ID: 4183134
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives.
    Betterle C; Zanette F; Pedini B; Presotto F; Rapp LB; Monciotti CM; Rigon F
    Diabetologia; 1984 Jun; 26(6):431-6. PubMed ID: 6381190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo.
    Iacovelli P; Sinagra JL; Vidolin AP; Marenda S; Capitanio B; Leone G; Picardo M
    Dermatology; 2005; 210(1):26-30. PubMed ID: 15604541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients.
    Colucci R; Lotti F; Dragoni F; Arunachalam M; Lotti T; Benvenga S; Moretti S
    Br J Dermatol; 2014 Oct; 171(4):786-98. PubMed ID: 25059078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of autoimmune atrophic gastritis in vitiligo.
    Zauli D; Tosti A; Biasco G; Miserocchi F; Patrizi A; Azzaroni D; Andriani G; Di Febo G; Callegari C
    Digestion; 1986; 34(3):169-72. PubMed ID: 3758513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positivity rates of antithyroid antibody, antinuclear antibody and thyroid peroxidase antibody in different types of vitiligo.
    Lim HK; Bae MI; Jeong KH; Shin MK; Lee MH
    Clin Exp Dermatol; 2016 Apr; 41(3):242-7. PubMed ID: 26452586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population.
    Nejad SB; Qadim HH; Nazeman L; Fadaii R; Goldust M
    Pak J Biol Sci; 2013 Jun; 16(12):570-4. PubMed ID: 24494526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoantibodies in children with vitiligo].
    Prćić S; Duran V; Poljacki M; Petrović L; Jakovljević A; Jokić M
    Med Pregl; 2004; 57(7-8):386-90. PubMed ID: 15626298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?
    Zettinig G; Tanew A; Fischer G; Mayr W; Dudczak R; Weissel M
    Clin Exp Immunol; 2003 Feb; 131(2):347-54. PubMed ID: 12562399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo epidemiological profile and the association with thyroid disease.
    Nunes DH; Esser LM
    An Bras Dermatol; 2011; 86(2):241-8. PubMed ID: 21603806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ-specific autoantibodies in coeliac disease: do they represent an epiphenomenon or the expression of associated autoimmune disorders?
    Volta U; De Franceschi L; Molinaro N; Tetta C; Bianchi FB
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):18-21. PubMed ID: 9265573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.